Safety of L1-79 in Adolescent and Adult Males With Autism

NCT02947048 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Autism

Interventions

DRUG: L1-79
DRUG: Placebo

Sponsor

Yamo Pharmaceuticals LLC